Advent Life Sciences has raised $215 million to back early-stage life science companies on both sides of the Atlantic. The fundraising positions the VC shop that founded Arrakis and KaNDy Therapeutics to place a fresh round of bets.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,